Products
2660 products
| Code | Description | Unit |
|---|---|---|
| EPY0001475 | Piroxicam for system suitability | EP unit |
| EPY0001476 | Pipemidic acid trihydrate | EP unit |
| EPY0001477 | Dexamethasone sodium phosphate for peak identification | EP unit |
| EPY0001478 | Thiopental for system suitability | EP unit |
| EPY0001479 | Oleic acid | EP unit |
| EPY0001480 | Sulfadiazine for identification of impurity F | EP unit |
| EPY0001481 | Metamizole impurity E - 4-N-Demethylanalgin | EP unit |
| EPY0001482 | Hydrocortisone acetate for peak identification | EP unit |
| EPY0001483 | Saw palmetto extract | EP unit |
| EPY0001484 | Medroxyprogesterone acetate for peak identification | EP unit |
| EPY0001485 | Rivastigmine for system suitability | EP unit |
| EPY0001486 | Pyridostigmine impurity B - 3-hydroxy-1-methylpyridinium | EP unit |
| EPY0001487 | Butyl methacrylate | EP unit |
| EPY0001488 | Methyl methacrylate | EP unit |
| EPY0001489 | 2-(Dimethylamino)ethyl methacrylate | EP unit |
| EPY0001490 | Methylphenidate impurity C | EP unit |
| EPY0001491 | Quinapril hydrochloride | EP unit |
| EPY0001492 | Doxylamine for system suitability | EP unit |
| EPY0001493 | Furosemide for peak identification | EP unit |
| EPY0001494 | Hydrochlorothiazide for peak identification | EP unit |
| EPY0001495 | Sulfadimidine for peak identification | EP unit |
| EPY0001496 | Cefoxitin sodium for peak identification | EP unit |
| EPY0001497 | 3-Trimethylsilyl-1-propanesulfonic acid sodium salt | EP unit |
| EPY0001498 | Lopinavir | EP unit |
| EPY0001499 | Nevirapine hemihydrate | EP unit |
| EPY0001500 | Coix seed HRS | EP unit |
| EPY0001501 | Orientvine stem HRS | EP unit |
| EPY0001502 | Quinapril for peak identification | EP unit |
| EPY0001503 | Quinapril for system suitability | EP unit |
| EPY0001504 | Human immunoglobulin BRP (ACA and Molecular size) | EP unit |
| EPY0001505 | Lopinavir for system suitability | EP unit |
| EPY0001506 | Lopinavir for peak identification | EP unit |
| EPY0001507 | Megestrol acetate for peak identification | EP unit |
| EPY0001508 | Picrotin | EP unit |
| EPY0001510 | Lactulose for peak identification | EP unit |
| EPY0001511 | Glibenclamide for peak identification | EP unit |
| EPY0001512 | Human Immunoglobulin BRP (Fc Function and Molecular size) | EP unit |
| EPY0001513 | Melphalan - Reference Spectrum | EP unit |
| EPY0001514 | Megestrol acetate | EP unit |
| EPY0001515 | Rivastigmine impurity D - 3-[(1R)-1-(dimethylamino)ethyl]phenyl ethyl(methyl)carbamate ((R)-enantiomer) | EP unit |
| EPY0001516 | Rivastigmine hydrogen tartrate | EP unit |
| EPY0001517 | Haloperidol for system suitability | EP unit |
| EPY0001518 | Haloperidol for peak identification | EP unit |
| EPY0001519 | Pioglitazone for system suitability | EP unit |
| EPY0001520 | Pioglitazone hydrochloride | EP unit |
| EPY0001521 | Amoxicillin trihydrate for performance verification | EP unit |
| EPY0001522 | Anastrozole | EP unit |
| EPY0001523 | Ursolic acid | EP unit |
| EPY0001524 | Megestrol acetate for system suitability | EP unit |
| EPY0001525 | Basic butylated methacrylate copolymer | EP unit |
| EPY0001528 | Picrotoxinin | EP unit |
| EPY0001529 | Buflomedil for peak identification | EP unit |
| EPY0001531 | Anastrozole impurity E - 2,2'-[5-(hydroxymethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile) | EP unit |
| EPY0001532 | Norethisterone acetate for system suitability | EP unit |
| EPY0001533 | Praziquantel for system suitability | EP unit |
| EPY0001534 | Amisulpride for system suitability | EP unit |
| EPY0001535 | Pemetrexed impurity mixture | EP unit |
| EPY0001536 | Fludarabine for system suitability | EP unit |
| EPY0001537 | Purified quillaia saponins | EP unit |
| EPY0001538 | Pemetrexed for system suitability | EP unit |
| EPY0001539 | Pemetrexed disodium heptahydrate | EP unit |
| EPY0001540 | Risedronate impurity E - 2-(pyridin-3-yl)ethane-1,1-diyl]bis(phosphonic acid) | EP unit |
| EPY0001541 | Risedronate sodium 2.5-hydrate | EP unit |
| EPY0001542 | Insulin glargine | EP unit |
| EPY0001543 | Actaea racemosa for assay CRS | EP unit |
| EPY0001544 | Insulin glargine for peak identification | EP unit |
| EPY0001545 | Chlorhexidine for system suitability | EP unit |
| EPY0001547 | Propylene glycol | EP unit |
| EPY0001548 | Labetalol impurity A - 2-Hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)-amino]ethyl]benzoic acid | EP unit |
| EPY0001549 | Oxcarbazepine impurity mixture | EP unit |
| EPY0001550 | Poly(vinyl alcohol) | EP unit |
| EPY0001551 | Abacavir for system suitability | EP unit |
| EPY0001552 | Abacavir for peak identification | EP unit |
| EPY0001553 | Ciclesonide | EP unit |
| EPY0001554 | Ciclesonide containing impurity A - (2'S)-2'-cyclohexyl-11b-hydroxy-3,20-dioxo-16bH-[1,3]dioxolo[4',5':16,17]pregna-1,4-diene-21-yl 2-methylpropanoate (S-epimer of ciclesonide) | EP unit |
| EPY0001555 | Ciclesonide impurity B - (2'R)-2'-cyclohexyl-11b,21-dihydroxy-16bH-[1,3]dioxolo[4',5':16,17]pregna-1,4-diene-3,20-dione | EP unit |
| EPY0001556 | Ciclesonide impurity C - (2 | EP unit |
| EPY0001557 | Poly (vinyl acetate) | EP unit |
| EPY0001558 | Risedronate impurity A | EP unit |
| EPY0001559 | Salvianolic acid B | EP unit |
| EPY0001560 | Tanshinone IIa | EP unit |
| EPY0001561 | Abacavir sulfate | EP unit |
| EPY0001562 | Doxylamine hydrogen succinate | EP unit |
| EPY0001563 | Mesalazine impurity A - 4-Aminophenol | EP unit |
| EPY0001564 | Quillaia saponin assay | EP unit |
| EPY0001565 | Recombinant Major Allergen rBet v 1 | EP unit |
| EPY0001566 | Recombinant Major Allergen rPhl p 5a | EP unit |
| EPY0001567 | Docusate sodium | EP unit |
| EPY0001568 | Isoquercitroside | EP unit |
| EPY0001569 | Mesalazine impurity C 2-Aminophenol | EP unit |
| EPY0001570 | Nitrofural impurity B | EP unit |
| EPY0001571 | Naloxone impurity D | EP unit |
| EPY0001572 | Atovaquone | EP unit |
| EPY0001573 | Atovaquone for system suitability | EP unit |
| EPY0001574 | Mesalazine for system suitability | EP unit |
| EPY0001575 | Bupivacaine impurity F | EP unit |
| EPY0001576 | Oxcarbazepine | EP unit |
| EPY0001577 | Isoprenaline impurity A | EP unit |
| EPY0001578 | Sildenafil citrate | EP unit |
| EPY0001579 | Sildenafil impurity A - 5-[2-ethoxy-5[(4-methylpiperazin-1-yl)sulfonyl]phenyl]-1-methyl- 3-(2-methylpropyl)-6,7-dihydro-1H-pyrazol[4,3-d]pyrimidin-7-one | EP unit |